<SEC-DOCUMENT>0001072613-18-000057-index.html : 20180129 <SEC-HEADER>0001072613-18-000057.hdr.sgml : 20180129 <ACCEPTANCE-DATETIME>20180129154432 ACCESSION NUMBER: 0001072613-18-000057 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180129 DATE AS OF CHANGE: 20180129 GROUP MEMBERS: ANTHONY A. FLORENCE, JR. GROUP MEMBERS: DAVID M. MOTT GROUP MEMBERS: FOREST BASKETT GROUP MEMBERS: M. JAMES BARRETT GROUP MEMBERS: NEA 14 GP, LTD GROUP MEMBERS: NEA PARTNERS 14, L.P. GROUP MEMBERS: PATRICK J. KERINS GROUP MEMBERS: PETER J. BARRIS GROUP MEMBERS: PETER W. SONSINI GROUP MEMBERS: RAVI VISWANATHAN GROUP MEMBERS: SCOTT D. SANDELL SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC CENTRAL INDEX KEY: 0001621227 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88833 FILM NUMBER: 18555393 BUSINESS ADDRESS: STREET 1: 60 JUBILEE AVENUE STREET 2: MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RX BUSINESS PHONE: 44 1235 430000 MAIL ADDRESS: STREET 1: 60 JUBILEE AVENUE STREET 2: MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RX FORMER COMPANY: FORMER CONFORMED NAME: Adaptimmune Ltd DATE OF NAME CHANGE: 20141001 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: New Enterprise Associates 14, L.P. CENTRAL INDEX KEY: 0001544328 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1954 GREENSPRING DRIVE STREET 2: SUITE 600 CITY: TIMONIUM STATE: MD ZIP: 21093 BUSINESS PHONE: 410-842-4000 MAIL ADDRESS: STREET 1: 1954 GREENSPRING DRIVE STREET 2: SUITE 600 CITY: TIMONIUM STATE: MD ZIP: 21093 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G/A <SEQUENCE>1 <FILENAME>adaptimmune-sch13ga2_18158.htm <DESCRIPTION>NEA 14 / ADAPTIMMUNE THERAPEUTICS PLC - 13GA (AMEND. #2) <TEXT> Document 1 - file: adaptimmune-sch13ga2_18158.htm
</DOCUMENT> </SEC-DOCUMENT>